Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Qishen Yiqi Dripping Pills for ischemic heart failure
ChiCTR-ONRC-14004407Phase 4Completed
- Sponsor
- First Teaching Hospital of Tianjin University of Traditional Chinese Medicine
- Start
- Mar 2014
- Modality
- Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of qishen yiqi dripping pills in Ischemic congestive heart failure (ICM-HF) (2 arms), sponsored by First Teaching Hospital of Tianjin University of Traditional Chinese Medicine. Primary endpoints: Minnesota Living with Heart Failure Questionnaire score and NYHA cardiac function classification. Started Mar 2014; status: completed.
02
Drugs
qishen yiqi dripping pills
03
Conditions
Ischemic congestive heart failure (ICM-HF)
Beyond the preview
Go deeper on ChiCTR-ONRC-14004407.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-ONRC-14004407.